Novel techniques of percutaneous sonography-guided surgical operations (SonoSurgery

经皮超声引导外科手术新技术（SonoSurgery

• 批准号: 10087309
• 金额: $ 49.9万
• 依托单位: SOVEREIGN MEDICAL LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2024
• 资助国家: 英国
• 起止时间: 2024 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10087309
• 关键词: Novel; techniques; percutaneous; sonography; guided

A Swiss company, Spirecut, has developed an innovative way to treat carpal tunnel and trigger finger using patented instruments (Sono-Instruments) and an incisionless technique conducted under ultrasound. Patients can be treated in an outpatient clinic in under 10 minutes, with no stitches and can resume normal activities immediately. In the current climate, with great strain on NHS resources and growing waiting lists for routine operations (over 7 million on NHS waiting list), this novel technique has the potential to reduce costs, improve NHS efficiency and get patients back to work faster, helping the economy post Covid. In this project, a collaborative UK-Swiss team will work to extend the Spirecut approach to other patient groups.The UK distributor of the Sono-Instruments, Sovereign Medical and health economists at the University of Southampton will work in partnership with Spirecut in Switzerland to conduct research on the extension of this technology for other conditions, such as Dupuytren disease, De Quervain and tennis elbow. Sovereign Medical will lead on recruiting to a joint UK-Swiss panel of expert advisors, including orthopaedic surgeons and interventional radiologists, who will assess suitability of the Spirecut technology these additional uses. The advisory group deliberations and consultations with a wider group of clinicians in a Delphi exercise will be used to assess the technical feasibility of the potential indications, and the economic impact that adopting these techniques would have on health services and medical innovation.The health economic team at Southampton will develop a model to aid decision making about further research and investment. The model will provide estimates of market value for each indication from a commercial perspective and estimates of budget impact and cost-effectiveness for the NHS. These estimates will be based on published information, real-world evidence sources and expert opinion, and will be updated as results from the Swiss clinical studies become available. This will provide a foundation for a future submission to the National Institute for Health and Care Excellence (NICE) with the aim of obtaining a recommendation for NHS adoption.

一家瑞士公司Spirecut开发了一种创新的方式，可以使用专利的仪器（Sono-Inspruments）和在超声波下进行的无切口技术来治疗腕管和触发手指。可以在不到10分钟的情况下在门诊诊所接受患者的治疗，没有针迹，并且可以立即恢复正常活动。在当前气候下，对NHS资源的压力很大，日益增长的常规操作清单（在NHS等待名单上超过700万），这种新颖的技术有可能降低成本，提高NHS的效率并使患者更快地工作，从而帮助Covid后经济有帮助。在这个项目中，一个协作的英国 - 瑞士团队将努力将Spirecut方法扩展到其他患者组。英国南安普敦大学的Sono-Inspruments，Sono-Insment，Sovereign Medical and Health经济学家将与瑞士的Spirecut合作，以延长此条件的其他条件，例如Dupuytren病，Den Quervain Quervain Quervain Quervain Quervain。主权医学将导致招募英国瑞士联合专家顾问小组，包括骨科医生和介入放射科医生，他们将评估这些其他用途的Spirecut技术的适用性。咨询小组在Delphi练习中与更广泛的临床医生进行的咨询小组审议和磋商将用于评估潜在迹象的技术可行性，并且采用这些技术将对卫生服务和医疗创新产生的经济影响。Southampton的卫生经济团队将开发一个模型来帮助做出进一步的研究和投资。该模型将从商业角度提供每种指示的市场价值的估计，并估计NHS的预算影响和成本效益。这些估计将基于已发表的信息，现实世界的证据来源和专家意见，并将随着瑞士临床研究的结果而更新。这将为未来向美国国家健康与护理研究所（NICE）提交的基础，目的是为了获得NHS采用的建议。